(Q24246595)

English

High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with metastatic breast cancer

scientific article

In more languages

Statements

scholarly article

0 references

0 references

1 reference

Europe PubMed Central

High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with metastatic breast cancer (English)

0 references

0 references

1 reference

based on heuristic

inferred from title

stem cell transplantation

1 reference

based on heuristic

inferred from title

metastatic breast cancer

1 reference

based on heuristic

inferred from title

1

0 references

Jane Marjoribanks

2

0 references

5

0 references

author name string

Russell Basser

3

0 references

Sarah E Hetrick

4

0 references

publication date

20 July 2005

0 references

Cochrane Database of Systematic Reviews

0 references

Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003142.PUB2

21 January 2018

Randomized trial of high-dose chemotherapy with autologous peripheral-blood stem-cell support compared with standard-dose chemotherapy in women with metastatic breast cancer: NCIC MA.16.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003142.PUB2

21 January 2018

Pegase 03: a prospective randomized phase III trial of FEC with or without high-dose thiotepa, cyclophosphamide and autologous stem cell transplantation in first-line treatment of metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003142.PUB2

21 January 2018

High-dose chemotherapy with haematopoietic stem cell transplantation for metastatic breast cancer patients: final results of the French multicentric randomised CMA/PEGASE 04 protocol

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003142.PUB2

21 January 2018

Up-front tandem high-dose chemotherapy compared with standard chemotherapy with doxorubicin and paclitaxel in metastatic breast cancer: results of a randomized trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003142.PUB2

21 January 2018

High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003142.PUB2

21 January 2018

Consolidation with high-dose combination alkylating agents with bone marrow transplantation significantly improves disease-free survival in hormone-insensitive metastatic breast cancer in complete remission compared with intensive standard-dose chem

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003142.PUB2

21 January 2018

The changing global patterns of female breast cancer incidence and mortality

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003142.PUB2

21 January 2018

High-dose chemotherapy with autologous bone marrow transplantation for the treatment of metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003142.PUB2

21 January 2018

The importance of dose intensity in chemotherapy of metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003142.PUB2

21 January 2018

Systematic reviews of chemotherapy and endocrine therapy in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003142.PUB2

21 January 2018

High-dose consolidation therapy with autologous stem-cell rescue in stage IV breast cancer: follow-up report

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003142.PUB2

21 January 2018

[Intensive chemotherapy and autograft of hematopoietic stem cells in the treatment of metastatic cancer: results of the national protocol Pegase 04]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003142.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose: a critical factor in cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003142.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose chemotherapy for breast cancer: the French PEGASE experience

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003142.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003142.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003142.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

The controversy over high-dose chemotherapy with autologous bone marrow transplant for breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003142.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/14651858.CD003142.PUB2

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24246595&oldid=1672274782"